Clinical Trials in Massachusetts

Showing 1721-1740 of 8,511 trials

Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

NCT03414684

This research study is studying a drug called Carboplatin with or without another study drug, Nivolumab as a possible treatment for triple-negative breast cancer that has spread to other parts of the body. The interventions involved in this study are: * Carboplatin * Nivolumab

Breast Cancer

Dana-Farber Cancer Institute78 participantsStarted Jan 2018

Stamford, Connecticut, United States • Bangor, Maine, United States • Boston, Massachusetts, United States +7 more locations

RECRUITINGPhase 214 miles

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02227251

A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who have no therapeutic options of demonstrated clinical benefit.

Diffuse Large B-cell Lymphoma

Karyopharm Therapeutics Inc244 participantsStarted Nov 2014

Tucson, Arizona, United States • San Francisco, California, United States • Santa Monica, California, United States +173 more locations

Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Find Trials by Condition in Massachusetts

Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Role of Parent Interpretation Bias in the Transmission of Anxiety to Children

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

SELUTION 4 De Novo Small Vessel IDE Trial

A Registry for Participants With Chronic Hypoparathyroidism

OP5-005 Using Omnipod 5 in Adults With Type 2

CERAMENT™| Bone Void Filler Device Registry

Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy

Effects of tDCS and tUS on Pain Perception in OA of the Knee

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome